at://
/
app.bsky.feed.post
/
3mobpdfzve22p
sign in
All
4
Record
2
Post
1
PostEmbed
1
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Tuspetinib/venetoclax/azacitidine produced high CR and MRD-negativity rates across molecular subgroups of older or unfit patients newly diagnosed AML. #EHA2026 #leusm #hematology www.onclive.com/view/tuspeti...
1d
OncLive
